Evaluation of biomimetic hyaluronic-based hydrogels with enhanced endogenous cell recruitment and cartilage matrix formation.
Adolescent
Aged
Animals
Becaplermin
/ pharmacology
Biomimetic Materials
/ pharmacology
Cartilage, Articular
/ drug effects
Cattle
Cell Movement
/ drug effects
Chondrogenesis
/ drug effects
Cross-Linking Reagents
/ pharmacology
Extracellular Matrix
/ drug effects
Humans
Hyaluronic Acid
/ pharmacology
Hydrogels
/ pharmacology
Mesenchymal Stem Cells
/ cytology
Middle Aged
Spheroids, Cellular
/ drug effects
Tyramine
/ pharmacology
Wound Healing
/ drug effects
Biomaterials
Cartilage repair
Cell migration
Endogenous cell recruitment
Osteochondral defect model
Journal
Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144
Informations de publication
Date de publication:
01 01 2020
01 01 2020
Historique:
received:
24
06
2019
revised:
06
11
2019
accepted:
07
11
2019
pubmed:
15
11
2019
medline:
6
1
2021
entrez:
15
11
2019
Statut:
ppublish
Résumé
Biomaterials play a pivotal role in cell-free cartilage repair approaches, where cells must migrate through the scaffold, fill the defect, and then proliferate and differentiate facilitating tissue remodeling. Here we used multiple assays to test the influence of chemokines and growth factors on cell migration and cartilage repair in two different hyaluronan (HA)-based hydrogels. We first investigated bone marrow Mesenchymal Stromal Cells (BMSC) migration in vitro, in response to different concentrations of platelet-derived growth factor-BB (PDGF-BB), chemokine ligand 5 (CCL5/RANTES) and stromal cell-derived factor 1 (SDF-1), using a 3D spheroid-based assay. PDGF-BB was selected as most favourable chemotactic agent, and MSC migration was assessed in the context of physical impediment to cell recruitment by testing Fibrin-HA and HA-Tyramine hydrogels of different cross-linking densities. Supplementation of PDGF-BB stimulated progressive migration of MSC through the gels over time. We then investigated in situ cell migration into the hydrogels with and without PDGF-BB, using a cartilage-bone explant model implanted subcutaneously in athymic mice. In vivo studies show that when placed into an osteochondral defect, both hydrogels supported endogenous cell infiltration and provided an amenable microenvironment for cartilage production. These processes were best supported in Fibrin-HA hydrogel in the absence of PDGF-BB. This study used an advanced preclinical testing platform to select an appropriate microenvironment provided by implanted hydrogels, demonstrating that HA-based hydrogels can promote the initial and critical step of endogenous cell recruitment and circumvent some of the clinical challenges in cartilage tissue repair. STATEMENT OF SIGNIFICANCE: The challenge of articular cartilage repair arises from its complex structure and architecture, which confers the unique mechanical behavior of the extracellular matrix. The aim of our research is to identify biomaterials for implants that can support migration of endogenous stem and progenitor cell populations from cartilage and bone tissue, in order to permanently replace damaged cartilage with the original hyaline structure. Here, we present an in vitro 3D spheroid-based migration assay and an osteochondral defect model, which provide the opportunity to assess biomaterials and biomolecules, and to get stronger experimental evidence of the not well-characterized dynamic process of endogenous cells colonization in an osteochondral defect. Furthermore, the delicate step of early cell migration into biomaterials towards functional tissue engineering is reproduced. These tests can be used for pre-clinical testing of newly developed material designs in the field of scaffold engineering.
Identifiants
pubmed: 31726249
pii: S1742-7061(19)30755-X
doi: 10.1016/j.actbio.2019.11.015
pii:
doi:
Substances chimiques
Cross-Linking Reagents
0
Hydrogels
0
Becaplermin
1B56C968OA
Hyaluronic Acid
9004-61-9
Tyramine
X8ZC7V0OX3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-303Subventions
Organisme : Medical Research Council
ID : MR-L022893
Pays : United Kingdom
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.